securities fraud

The Schall Law Firm is investigating $DXST for potential securities violations, including false statements and material information failures. Investors who suffered losses may participate.

Law firm launches investigation into $CUPR for potential securities violations, misleading statements, and material information failures affecting shareholders.

Schall Law Firm investigates $ZONE for alleged false statements and failure to disclose material information. Firm seeks affected shareholders to join the probe.

Schall Law Firm investigates $APUS, $ETS, $DXST for alleged securities fraud involving false statements and material disclosure failures. Affected shareholders may participate in class action.

Securities class action filed against $PINS over alleged false statements on ad revenues and tariff impacts. Stock plunged 16.8% in February 2026.

PennyMac Financial ($PFSI) stock collapsed 33.3% to $99.92 after weak Q4 results; securities investigation launched exploring class action lawsuit for alleged material misstatements.

Class action lawsuit filed against Coty alleging executives made false statements about growth and profitability between November 2025 and February 2026.

Class action lawsuit filed against $TRIP alleging false statements about regulatory risks from monopolistic practices. Lead plaintiff deadline set for May 11, 2026.

Class action lawsuit filed against $ALDYA alleging false statements about reproxalap clinical trial results. Claims inconsistent data, unreliable findings.

Class action lawsuit filed against $BSX alleging material misstatements about U.S. electrophysiology segment growth. Eligible period: July 23, 2025 to February 3, 2026.

Class action lawsuit filed against $ALIGHT alleging executives made false statements about CEO prospects, capital returns, and revenue targets. Eligible investors had securities between Nov 2024-Feb 2026.

Class action lawsuit filed against $PSIX alleging materially false statements about data center demand and manufacturing costs. Investors who purchased shares May 2025-March 2026 affected.

Class action lawsuit filed against $MNDY alleging materially false statements about revenue expansion and sales cycle expectations from September 2025 to February 2026.

Class action lawsuit filed against Concorde International Group alleging fraudulent stock promotion, social media misinformation, and insider share dumping through offshore accounts.

Class action lawsuit filed against $EOSE alleging securities fraud over undisclosed production issues, battery downtime, and misleading guidance from November 2025 to February 2026.

Class action lawsuit filed against $IBRX over alleged misleading statements regarding Anktiva capabilities between January-March 2026. Lead plaintiff deadline May 26.

Grocery Outlet faces securities fraud lawsuit over failed expansion strategy. Stock plunged 27.9% after March 2026 store closure announcement. Investors have until May 15, 2026 deadline.

$SES plunged 36.8% March 5 after weak Q4 results and 2026 guidance. Class action investigation underway alleging misleading analyst information.

Rosen Law Firm urges Snowflake investors with losses exceeding $100K to seek counsel before April 27, 2026 class action deadline.

ImmunityBio faces class action lawsuit alleging false Anktiva claims. Stock plummeted 21% after FDA warning letter. Lead plaintiff deadline May 26, 2026.